PsA Returns

People with psaratic (PsA) shouldn't be too quick to go off their medications after experiencing remission, according to a small study published recently in the Annual of the Rheumatic Disease.
Researchers of the university of Erldagen- Nuremberg in Germary looked at 26 people with long term PsA who have been in remission for at least six months and who were being treated with either a conventional disease modifying antirheumatic drug (DMARD) or a type of biological called a TNF inhibitors. The… read more